Related Experiment Video
Updated: May 31, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation
Bin Wu1, Gabriela E Davey, Alexey A Nazarov
1Division of Structural and Computational Biology, School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Singapore.
Platinum drugs target DNA by binding to guanine bases. DNA structure influences drug binding and effectiveness, impacting cancer therapy development.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Biochemistry
Background:
- Heavy metal compounds, particularly platinum drugs, exhibit therapeutic potential due to their ability to form strong bonds with macromolecules like DNA.
- The therapeutic activity of platinum drugs is primarily attributed to their interaction with the major groove nitrogen atom of guanine bases in DNA.
Purpose of the Study:
- To investigate the site selectivity of transition metal compounds, specifically platinum, within the nucleosome core of DNA using crystallographic analysis.
- To elucidate how DNA structural parameters and conformational features influence the initial guanine-metal bond formation and subsequent adduct formation in both naked and nucleosomal DNA.
Main Methods:
- Crystallographic analysis of transition metal-DNA interactions within the nucleosome core.
- Comparative analysis of platinum drug adduct formation in naked DNA versus nucleosomal DNA.
Main Results:
- Steric accessibility, governed by DNA structural parameters, modulates the initial guanine-metal bond formation.
- DNA conformational features dictate similarities and differences in platinum adduct formation between naked and nucleosomal DNA states.
- Structural features promoting initial platinum-guanine bond formation can inhibit cross-link generation, leading to therapeutically ineffective monofunctional adducts.
Conclusions:
- Findings illuminate DNA structure-dependent reactivity in metal-DNA interactions.
- Provides a novel framework for understanding how metal compounds interact with DNA, particularly within chromatin.
- Suggests potential for developing improved chromatin-targeting medicinal agents by considering DNA structural influences on drug binding.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC (Crosslinking of Small Molecules to Isolate Chromatin)
Published on: January 20, 2016
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Related Concept Videos
Single-Strand DNA Binding Proteins
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Inhibitors of Bacterial DNA Synthesis
Overview of DNA Repair
Chemically...
Base-pairing and DNA Repair
Spontaneous and Induced Mutations